Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-163478
Filing Date
2025-07-23
Accepted
2025-07-23 17:08:09
Documents
4

Document Format Files

Seq Description Document Type Size
1 424B5 d945355d424b5.htm 424B5 806564
2 GRAPHIC g944622g02v02.jpg GRAPHIC 30815
3 GRAPHIC g945355g01t12.jpg GRAPHIC 57432
4 GRAPHIC g945355g50p50.jpg GRAPHIC 51140
  Complete submission text file 0001193125-25-163478.txt   993470
Mailing Address 7 BD HAUSSMANN PARIS France
Business Address 7 BD HAUSSMANN PARIS France 01 53 83 09 63
Abivax S.A. (Filer) CIK: 0001956827 (see all company filings)

EIN.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-288884 | Film No.: 251143804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)